2009 Atherosclerosis Gordon Research Conference

描述（由申请人提供）： 第19届戈登动脉粥样硬化研究会议将于2009年6月21日至26日在新罕布什尔州蒂尔顿的蒂尔顿学校举行。该会议自1973年以来每两年举行一次。该会议享有全球声誉，并汇集了来自各个职业水平和各种背景的高素质参与者，以“非正式”的方式，高质量地深入讨论动脉粥样硬化知识前沿的研究。这个综合性会议在动脉粥样硬化研究中特别有价值，因为这种复杂，多方面的疾病的起源和进展涉及多个不同的学科。动脉粥样硬化戈登会议将提供动脉粥样硬化病理生物学最重要的最新进展的概述。会议将讨论动脉粥样硬化病变的发展，进展和解决的各个方面，以及目前和未来的治疗方法。在整个过程中，将特别强调与动脉粥样硬化研究相关的尖端技术和资源。计划举行九次会议，将涉及以下主题：1.巨噬细胞异质性; 2.动脉粥样硬化的系统生物学; 3.动脉粥样硬化的基因组学和遗传学; 4.干细胞和谱系获取; 5.病变动力学和钙化性血管病变; 6.脂质、脂蛋白和代谢异常; 7.病变可逆性; 8.慢性炎症; 9.未来的治疗和诊断。这次会议将成为动脉粥样硬化研究领域新知识整合的主要工具。为了促进跨学科的对话，将邀请代表不同但重叠的研究领域的演讲者，如干细胞生物学，基因组学，脂蛋白，糖尿病和血管生物学。会议将鼓励妇女和少数民族的参与。一些受邀演讲者将是年轻科学家，还将通过海报会议鼓励年轻科学家和受训人员参加。该会议将全面概述动脉粥样硬化的当前研究，重点关注该领域最新和最令人兴奋的发展以及未来的治疗方法。(End摘要）

DESCRIPTION (provided by applicant): The 19th Gordon Research Conference on Atherosclerosis will be held at Tilton School in Tilton, New Hampshire on June 21-26, 2009. This conference has been held every two years since 1973. The conference enjoys a worldwide reputation, and brings together highly qualified participants from all levels of career status and from a variety of backgrounds for "off-the-record," high quality intensive discussions of research at the frontiers of knowledge in atherosclerosis. This integrative conference has been particularly valuable in atherosclerosis research because of the multiple and distinct disciplines that bear on the origin and progression of this complex, multifaceted disease. The Atherosclerosis Gordon Conference will provide an overview of the most important recent developments in the pathobiology of atherosclerosis. The meeting will discuss all aspects of atherosclerotic lesion development, progression and resolution as well as current and future therapeutic approaches. Throughout, special emphasis will be placed on cutting edge technologies and resources that are relevant to the study of atherosclerosis. Nine sessions are planned and will cover the following topics: 1. Macrophage heterogeneity; 2. Systems biology of atherosclerosis; 3. Genomics and genetics of atherosclerosis; 4. Stem cells and lineage acquisition; 5. Lesion dynamics and calcific vasculopathy; 6. Lipids, lipoproteins and dysmetabolic conditions; 7. Lesion reversibility; 8. Chronicity of inflammation; 9. Future therapeutics and diagnostics. The conference will be a major vehicle for the integration of new knowledge in the field of atherosclerosis research. In order to stimulate an interdisciplinary dialogue, speakers will be invited who represent distinct but overlapping areas of research such as; stem cell biology, genomics, lipoproteins, diabetes and vascular biology. The conference will encourage the participation of women and minorities. Some of the invited speakers will be junior scientists and participation of junior scientists and trainees will also be encouraged through poster sessions. The conference will provide a comprehensive overview of current research on atherosclerosis with a focus on the latest and most exciting developments in the field and future therapeutic approaches. (End of Abstract)